LJI Professor Alessandro Sette, Dr.Bio.Sci. (left) and LJI Research Assistant Professor Alba Grifoni, Ph.D.
Newswise — LA JOLLA, CA—Researchers at La Jolla Institute for Immunology () are leading new research to combat the rapidly spreading "clade 1" strain of mpox virus. Their laboratories aim to guide vaccine development in the Democratic Republic of Congo and a growing number of African countries.
, is a world-renowned T cell expert and Co-Director of the LJI Center for Vaccine Innovation.. His research shows how human T cells target viruses to prevent severe disease. His laboratory is working to accelerate new mpox vaccine development by analyzing mpox patient samples and measuring current mpox vaccine responses. Sette can also speak to how mpox mutations compare with SARS-CoV-2 mutations.
, is a leading scientist in the field of T cell research and pandemic preparedness. Her laboratory combines experimental and bioinformatics approaches to shed light on emerging infectious diseases. Along with Sette, Grifoni is investigating how the immune system recognizes the clade 1 mpox strain. , the Sette and Grifoni laboratories collaborated to show how T cells target mpox—and how vaccines can boost this immune system protection.
Sette and Grifoni are both members of . The researchers have also received significant funding from the National Institutes of Health, the SARS-CoV-2 Assessment of Viral Evolution (SAVE) consortium, and the Coalition for Epidemic Preparedness Innovations (CEPI) to investigate immune responses to emerging viruses with pandemic potential.
To arrange an interview with these experts, please contact:
Gina Kirchweger, Ph.D., LJI Chief of Communications/Chief of Staff, [email protected] / 858.752.6640
Madeline McCurry-Schmidt, LJI Science Writer, [email protected] / 858.752.6617
Additional resources:
About La Jolla Institute
La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease. Visit for more information.
RSS